A human-derived, ultra-long-acting GLP-1 injection independently researched and developed by Innogen, a Shanghai-based ...
CHATHAM, N.J. - Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP), a clinical-stage biotech company with a market capitalization of $28 million, announced today positive outcomes from its Phase 1 ...
Apogee Therapeutics, Inc. (NASDAQ: APGE) has announced the dosing of the first patient in the part B portion of the phase 2 ...
The stock is trading at 1.0150, up 0.6573, gaining 183.7573% on volume of over 422 Million shares, with a day’s high of $1.11 ...
OSRS, Elden Ring, and other FromSoftware icons all come together in a vibrant new soulslike RPG that is getting serious raves ...
Invivyd data shows strong potency and prolonged antibody levels in trials. Q4 Pemgarda revenue rose 48% to $13.8 million.
Enrollment of Part A completed ahead of schedule and exceeded enrollment target with 123 patients enrolledPart A 16-week proof-of-concept data ...
Oral GLP-1 formulations represent a groundbreaking advance in obesity treatment, offering improved patient comfort and ...
Half-Life and Doom are remembered as the defining games of the FPS golden era, but one vicious and vivid shooter deserves the ...
Anyone can contribute to The Roar and have their work featured alongside some of Australia’s most prominent sports journalists. As part of a series profiling the expected Round 1 sides for all ...
Of the $3.7 trillion in profits they have earned as an industry since 1969, nearly half or a staggering $1.8 trillion was gobbled up as fees, according to estimates by LCH Investments, a fund of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback